Internalization of staphylococcal leukotoxins that bind and divert the C5a receptor is required for intracellular Ca2+ mobilization by human neutrophils

Cellular Microbiology

Volumn 17, Issue 8, 2015, Pages 1241-1257

  Tawk, Mira Y ^a   Zimmermann Meisse, Gaëlle ^a   Bossu, Jean Louis ^b   Potrich, Cristina ^c   Bourcier, Tristan ^a   Dalla Serra, Mauro ^c   Poulain, Bernard ^b   Prévost, Gilles ^a   Jover, Emmanuel ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b Institut des Neurosciences Cellulaires et Intégratives UPR3212   (France)

^c FONDAZIONE BRUNO KESSLER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C5A RECEPTOR; LEUKOTOXIN; PANTON VALENTINE LEUKOCIDIN; STAPHYLOCOCCUS TOXIN; BACTERIAL TOXIN; CALCIUM; EXOTOXIN; LEUKOCIDIN; PANTON-VALENTINE LEUKOCIDIN; PROTEIN BINDING;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CELL MEMBRANE; CONTROLLED STUDY; ELECTROPHYSIOLOGICAL PROCEDURES; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTERNALIZATION; MEMBRANE RESISTANCE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; STAPHYLOCOCCUS AUREUS; U937 CELL LINE; CELL CULTURE; ELECTROPHYSIOLOGY; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; MONOCYTE; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); STAPHYLOCOCCUS;

BACTERIAL TOXINS; CALCIUM; CELLS, CULTURED; ELECTROPHYSIOLOGICAL PHENOMENA; EXOTOXINS; HOST-PATHOGEN INTERACTIONS; HUMANS; LEUKOCIDINS; MONOCYTES; NEUTROPHILS; PROTEIN BINDING; RECEPTOR, ANAPHYLATOXIN C5A; STAPHYLOCOCCUS AUREUS;

EID: 84937141329     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/cmi.12434     Document Type: Article

References (67)

1. Alonzo, F., and Torres, V.J. (2014) The bicomponent pore-forming leucocidins of Staphylococcus aureus. Microbiol Mol Biol Rev 78: 199-230.
2. Alonzo, F., III, Kozhaya, L., Rawlings, S.A., Reyes-Robles, T., DuMont, A.L., Myszka, D.G., etal. (2013) CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature 493: 51-55.
3. Ames, R.S., Lee, D., Foley, J.J., Jurewicz, A.J., Tornetta, M.A., Bautsch, W., etal. (2001) Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models. J Immunol 166: 6341-6348.
4. Archer, G.L. (1998) Staphylococcus aureus: a well-armed pathogen. Clin Infect Dis 26: 1179-1181.
5. 2+-activation from the pore-forming function of the bi-component Panton-Valentine leucocidin in human PMNs. FEBS Lett 461: 280-286.
6. Bénard, M., Gonzalez, B.J., Schouft, M.-T., Falluel-Morel, A., Vaudry, D., Chan, P., etal. (2004) Characterization of C3a and C5a receptors in rat cerebellar granule neurons during maturation: neuroprotective effect of C5a against apoptotic cell death. J Biol Chem 279: 43487-43496.
7. Colin, D.A., and Monteil, H. (2003) Control of the oxidative burst of human neutrophils by staphylococcal leukotoxins. Infect Immun 71: 3724-3729.
8. Colin, D.A., Mazurier, I., Sire, S., and Finck-Barbançon, V. (1994) Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation. Infect Immun 62: 3184-3188.
9. Comai, M., Serra, M.D., Coraiola, M., Werner, S., Colin, D.A., Monteil, H., etal. (2002) Protein engineering modulates the transport properties and ion selectivity of the pores formed by staphylococcal γ-haemolysins in lipid membranes. Mol Microbiol 44: 1251-1267.
10. Couppié, P., and Prévost, G. (1997) Les Leucotoxines Staphylococciques. Ann Dermatol Venereol 124: 740-748.
11. Dalla Serra, M., and Menestrina, G. (2000) Characterization of molecular properties of pore-forming toxins with planar lipid bilayers. In Bacterial Toxins: Methods and Protocols. New York: Humana Press, pp. 171-188.
12. Dalla Serra, M., Coraiola, M., Viero, G., Comai, M., Potrich, C., Ferreras, M., etal. (2005) Staphylococcus aureus bicomponent γ-Hemolysins, HlgA, HlgB, and HlgC, can form mixed pores containing all components. J Chem Inf Model 45: 1539-1545.
13. 2+ accumulation, storage, and release. J Biol Chem 266: 20159-20167.
14. Ferreras, M., Höper, F., Dalla Serra, M., Colin, D.A., Prévost, G., and Menestrina, G. (1998) The interaction of Staphylococcus aureus bi-component γ-hemolysins and leucocidins with cells and lipid membranes. Biochim Biophys Acta 1414: 108-126.
15. Finck-Barbançon, V., Prévost, G., and Piémont, Y. (1991) Improved purification of leukocidin from Staphylococcus aureus and toxin distribution among hospital strains. Res Microbiol 142: 75-85.
16. Finck-Barbançon, V., Duportail, G., Meunier, O., and Colin, D.A. (1993) Pore formation by a two-component leukocidin from Staphylococcus aureus within the membrane of human polymorphonuclear leukocytes. Biochim Biophys Acta 1182: 275-282.
17. Foster, T.J., Geoghegan, J.A., Ganesh, V.K., and Hook, M. (2014) Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus. Nat Rev Microbiol 12: 49-62.
18. Galione, A., Morgan, A.J., Arredouani, A., Davis, L.C., Rietdorf, K., Ruas, M., and Parrington, J. (2010) NAADP as an intracellular messenger regulating lysosomal calcium-release channels. Biochem Soc Trans 38: 1424-1431.
19. Gauduchon, V., Werner, S., Prévost, G., Monteil, H., and Colin, D.A. (2001) Flow cytometric determination of Panton-Valentine leucocidin S component binding. Infect Immun 69: 2390-2395.
20. Goldsmith, Z.G., and Dhanasekaran, D.N. (2007) G protein regulation of MAPK networks. Oncogene 26: 3122-3142.
21. Graves, S.F., Kobayashi, S.D., Braughton, K.R., Whitney, A.R., Sturdevant, D.E., Rasmussen, D.L., etal. (2012) Sublytic concentrations of Staphylococcus aureus Panton-Valentine leukocidin alter human PMN gene expression and enhance bactericidal capacity. J Leukoc Biol 92: 361-374.
22. de Haas, C.J.C., Veldkamp, K.E., Peschel, A., Weerkamp, F., Van Wamel, W.J.B., Heezius, E.C.J.M., etal. (2004) Chemotaxis inhibitory protein of Staphylococcus aureus, a bacterial antiinflammatory agent. J Exp Med 199: 687-695.
23. Inoshima, I., Inoshima, N., Wilke, G.A., Powers, M.E., Frank, K.M., Wang, Y., and Bubeck Wardenburg, J. (2011) A Staphylococcus aureus pore-forming toxin subverts the activity of ADAM10 to cause lethal infection in mice. Nat Med 17: 1310-1314.
24. 2+ influx and IL-2 production in T lymphocytes. J Immunol 170: 4441-4449.
25. Jacob, A., Hack, B., Chiang, E., Garcia, J.G.N., Quigg, R.J., and Alexander, J.J. (2010) C5a alters blood-brain barrier integrity in experimental lupus. FASEB J 24: 1682-1688.
26. Jia, N., Semba, U., Nishiura, H., Kuniyasu, A., Nsiama, T.K., Nishino, N., and Yamamoto, T. (2010) Pivotal advance: interconversion between pure chemotactic ligands and chemoattractant/secretagogue ligands of neutrophil C5a receptor by a single amino acid substitution. J Leukoc Biol 87: 965-975.
27. Joubert, O., Viero, G., Keller, D., Martinez, E., Colin, D.A., Monteil, H., etal. (2006) Engineered covalent leucotoxin heterodimers form functional pores: insights into S-F interactions. Biochem J 396: 381-389.
28. 2+ rise in neurons, signaling through acidic stores and activation of store-operated channels. Cell Microbiol 15: 742-758.
29. Kew, R.R., Peng, T., DiMartino, S.J., Madhavan, D., Weinman, S.J., Cheng, D., and Prossnitz, E.R. (1997) Undifferentiated U937 cells transfected with chemoattractant receptors: a model system to investigate chemotactic mechanisms and receptor structure/function relationships. J Leukoc Biol 61: 329-337.
30. Klos, A., Wende, E., Wareham, K.J., and Monk, P.N. (2013) International union of basic and clinical pharmacology. LXXXVII. Complement peptide C5a, C4a, and C3a receptors. Pharmacol Rev 65: 500-543.
31. Lappin, E., and Ferguson, A.J. (2009) Gram-positive toxic shock syndromes. Lancet Infect Dis 9: 281-290.
32. 2+ signalling. FEBS J 276: 1800-1816.
33. Laventie, B.J., Potrich, C., Atmanene, C., Saleh, M., Joubert, O., Viero, G., etal. (2013) p-Sulfonato-calix[n]arenes inhibit staphylococcal bicomponent leukotoxins by supramolecular interactions. Biochem J 450: 559-571.
34. Lonchamp, E., Dupont, J.-L., Wioland, L., Courjaret, R.L., Mbebi-Liegeois, C., Jover, E., etal. (2010) Clostridium perfringens epsilon toxin targets granule cells in the mouse cerebellum and stimulates glutamate release. PLoS ONE 5: e13046.
35. Lowy, F.D. (1998) Staphylococcus aureus infections. New Engl J Med 339: 520-532.
36. McCormick, J.K., Yarwood, J.M., and Schlievert, P.M. (2001) Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol 55: 77-104.
37. Mathieu, M.-C., Sawyer, N., Greig, G.M., Hamel, M., Kargman, S., Ducharme, Y., etal. (2005) The C3a receptor antagonist SB 290157 has agonist activity. Immunol Lett 100: 139-145.
38. Menestrina, G. (1986) Ionic channels formed by Staphylococcus aureus alpha-toxin: voltage-dependent inhibition by divalent and trivalent cations. J Membr Biol 90: 177-190.
39. Menestrina, G., Dalla Serra, M., Comai, M., Coraiola, M., Viero, G., Werner, S., etal. (2003) Ion channels and bacterial infection: the case of β-barrel pore-forming protein toxins of Staphylococcus aureus. FEBS Lett 552: 54-60.
40. Meunier, O., Falkenrodt, A., Monteil, H., and Colin, D.A. (1995) Application of flow cytometry in toxinology: pathophysiology of human polymorphonuclear leukocytes damaged by a pore-forming toxin from Staphylococcus aureus. Cytometry 21: 241-247.
41. Meyer, F., Girardot, R., Piémont, Y., Prévost, G., and Colin, D.A. (2009) Analysis of the specificity of panton-valentine leucocidin and gamma-hemolysin F component binding. Infect Immun 77: 266-273.
42. Miles, G., Jayasinghe, L., and Bayley, H. (2006) Assembly of the bi-component leukocidin pore examined by truncation mutagenesis. J Biol Chem 281: 2205-2214.
43. Monk, P.N., Scola, A.M., Madala, P., and Fairlie, D.P. (2007) Function, structure and therapeutic potential of complement C5a receptors. Br J Pharmacol 152: 429-448.
44. Mueller, M., Herzog, C., Larmann, J., Schmitz, M., Hilfiker-Kleiner, D., Gessner, J.E., and Theilmeier, G. (2013) The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration. Immunobiology 218: 1131-1138.
45. Nishiura, H., Chen, J., Ota, Y., Semba, U., Higuchi, H., Nakashima, T., and Yamamoto, T. (2010) Base of molecular mimicry between human ribosomal protein S19 dimer and human C5a anaphylatoxin. Int Immunopharmacol 10: 1541-1547.
46. Olson, R., Nariya, H., Yokota, K., Kamio, Y., and Gouaux, E. (1999) Crystal structure of staphylococcal LukF delineates conformational changes accompanying formation of a transmembrane channel. Nat Struct Mol Biol 6: 134-140.
47. Otto, M. (2014) Staphylococcus aureus toxins. Curr Opin Microbiol 17: 32-37.
48. Periasamy, M., and Kalyanasundaram, A. (2007) SERCA pump isoforms: their role in calcium transport and disease. Muscle Nerve 35: 430-442.
49. Popov, L., Kovalski, J., Grandi, G., Bagnoli, F., and Amieva, M.R. (2014) Three-dimensional human skin models to understand Staphylococcus aureus skin colonization and infection. Front Immunol 5: 41.
50. Postma, B., Kleibeuker, W., Poppelier, M.J.J.G., Boonstra, M., Van Kessel, K.P.M., Van Strijp, J.A.G., and de Haas, C.J.C. (2005) Residues 10-18 within the C5a receptor N terminus compose a binding domain for chemotaxis inhibitory protein of Staphylococcus aureus. J Biol Chem 280: 2020-2027.
51. Prévost, G., Mourey, L., Colin, D.A., and Menestrina, G. (2001) Staphylococcal pore forming toxins. Curr Top Microbiol Immunol 257: 53-83.
52. Proctor, L.M., Arumugam, T.V., Shiels, I., Reid, R.C., Fairlie, D.P., and Taylor, S.M. (2004) Comparative anti-inflammatory activities of antagonists to C3a and C5a receptors in a rat model of intestinal ischaemia/reperfusion injury. Br J Pharmacol 142: 756-764.
53. Reyes-Robles, T., Alonzo, F., III, Kozhaya, L., Lacy, D.B., Unutmaz, D., and Torres, V.J. (2013) Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection. Cell Host Microbe 14: 453-459.
54. Rosen, D., Lewis, A.M., Mizote, A., Thomas, J.M., Aley, P.K., Vasudevan, S.R., etal. (2009) Analogues of the nicotinic acid adenine dinucleotide phosphate (NAADP) antagonist ned-19 indicate two binding sites on the NAADP receptor. J Biol Chem 284: 34930-34934.
55. Rothermel, E., Götze, O., Zahn, S., and Schlaf, G. (2000) Analysis of the tissue distribution of the Rat C5a receptor and inhibition of C5a-mediated effects through the use of two moabs. Scand J Immunol 52: 401-410.
56. Shrestha, A., Shi, L., Tanase, S., Tsukamoto, M., Nishino, N., Tokita, K., and Yamamoto, T. (2004) Bacterial chaperone protein, skp, induces leukocyte chemotaxis via C5a receptor. Am J Pathol 164: 763-772.
57. Spaan, A.N., Henry, T., van Rooijen, W.J., Perret, M., Badiou, C., Aerts, P.C., etal. (2013) The staphylococcal toxin Panton-Valentine leukocidin targets human c5a receptors. Cell Host Microbe 13: 584-594.
58. Spaan, A.N., Vrieling, M., Wallet, P., Badiou, C., Reyes-Robles, T., Ohneck, E.A., etal. (2014) The staphylococcal toxins γ-haemolysin AB and CB differentially target phagocytes by employing specific chemokine receptors. Nat Commun 5: 5438.
59. 2+ channels in the membrane of human polymorphonuclear neutrophils. J Membrane Biol 162: 209-216.
60. Sumichika, H., Sakata, K., Sato, N., Takeshita, S., Ishibuchi, S., Nakamura, M., etal. (2002) Identification of a potent and orally active non-peptide C5a receptor antagonist. J Biol Chem 277: 49403-49407.
61. Vandenesch, F., Lina, G., and Henry, T. (2012) Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides: a redundant arsenal of membrane-damaging virulence factors? Front Cell Infect Microbiol 2: 12.
62. Werner, S., Colin, D.A., Coraiola, M., Menestrina, G., Monteil, H., and Prévost, G. (2002) Retrieving biological activity from LukF-PV mutants combined with different S components implies compatibility between the stem domains of these staphylococcal bicomponent leucotoxins. Infect Immun 70: 1310-1318.
63. Wilke, G.A., and Bubeck Wardenburg, J. (2010) Role of a disintegrin and metalloprotease 10 in Staphylococcus aureus α-hemolysin-mediated cellular injury. Proc Natl Acad Sci USA 107: 13473-13478.
64. Woodin, A.M. (1960) Purification of the two components of leucocidin from Staphylococcus aureus. Biochem J 75: 158-165.
65. Yanai, M., Rocha, M.A., Matolek, A.Z., Chintalacharuvu, A., Taira, Y., Chintalacharuvu, K., and Beenhouwer, D.O. (2014) Separately or combined, LukG/LukH is functionally unique compared to other staphylococcal bicomponent leukotoxins. PLoS ONE 9: e89308.
66. Yoong, P., and Pier, G.B. (2012) Immune-activating properties of Panton-Valentine leukocidin improve the outcome in a model of methicillin-resistant Staphylococcus aureus pneumonia. Infect Immun 80: 2894-2904.
67. Yoong, P., and Torres, V.J. (2013) The effects of Staphylococcus aureus leukotoxins on the host: cell lysis and beyond. Curr Opin Microbiol 16: 63-69.